Second quarter 2016 grew at an annual rate of just 1.2% — well below expectations of 2.6% — thanks to continued weakness in business investment. That alone should give the Federal Reserve reason to rethink raising rates anytime soon. Even after the U.S. has given businesses a great deal of tools to drive such investment,…
DetailsJust when you thought it was safe to go back outside, the Zika virus story is making headlines again. Nowadays, 10 new cases on the virus have appeared in Miami… and the Centers for Disease Control (CDC) is warning pregnant women to stay away. Eight cases were confirmed in Arkansas. Another 26 cases were discovered…
Details“Seven Years Later, Recovery Remains the Weakest of the Post-World War II Era…” That was the Wall Street Journal headline your editor woke up to yesterday. Looking for a thoughtful idea to detail for you dear reader, I bit. I read it. I reread it. And I was left with nothing. So much so I…
DetailsThe race for the Oval office is on fire. Both sides of the aisle are at each other’s throat, demanding change. Just days after Donald Trump clinched the Republican nomination for the U.S. presidential ticket the Democratic National Committee commenced its nomination of Hillary Clinton. All as the nail biting race for the White House…
DetailsIf you’re reading this article, you’re on your way to becoming a successful investor. The headline is an intentionally bad one. Few investors are interested in when to sell a stock. I can tell you from experience, in six months I can check web traffic data and this article will be one of the least…
Details“Near-term risks to the economic outlook have diminished…” Wait…what? That’s the key line from yesterday’s statement by the Federal Reserve. Does it say things are getting better? Will get better? Are getting worse? It says all of those things and none of those things. It’s meaningless. They said nothing and nothing changed. In fact, according…
DetailsAfter reaching a June 2016 high of $51.62, oil prices have slumped 16%. Supply and demand issues are returning, as production resumes in roiled hot spots, such as Nigeria and Canada, where firestorms cut higher levels of oil output. Renewed strength in the U.S. dollar is putting pressure on the resource at well. Others warn…
DetailsThe election is tightening. Betting odds are too. Honestly though, we’re not paying much attention to it all. Three reasons why. One, the thing which will really decide this election is not yet known. That one big, unscripted, unexpected moment which tilts the tables is nothing more than a known unknown at this point. Two,…
DetailsIt’s coming down to the wire. In July 2015, The Cheap Investor made a recommendation to buy Pain Therapeutics (PTIE) at just $1.83 a share. Last checked, the stock was up to $2.71 for a potential gain of 48%. And we see no reason to exit. As we near a September 25 PDUFA date for…
DetailsIt’s coming down the wire. In just four months, Donald Trump or Hillary Clinton will be elected the next president of the United States. And there’s only one certainty – it’ll be a nail-biting fight to the finish. At the moment, about 43% of registered voters say they support Clinton. About 40% say they want…
DetailsThe results are in and they’re spectacular not as bad as expected! That’s the best way to describe this earnings season. If you’re watching the headlines, all seems well. So far 70 S&P 500 companies have reported earnings. A total of 47 have “beat” expectations. However, there’s no real turnaround at all. Average earnings for…
DetailsIn the March 2016 issue of The Cheap Investor, we recommended buying McDermott International (MDR) at just $2.97 a share. While the stock was speculative at the time, due to uncertainty over the price of oil, we argued it had the ingredients to move 50% to 100% higher, as oil turned around. As of this…
Details